Publicaciones (135) Publicaciones de Emilio José Sanz Álvarez

2024

  1. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)

    Schizophrenia Research, Vol. 268, pp. 165-174

  2. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance

    Schizophrenia Research, Vol. 268, pp. 53-59

  3. An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance

    Schizophrenia Research, Vol. 268, pp. 60-65

  4. Beyond lectures and practical courses: Teaching pharmacology using imaginative pedagogical tools

    Pharmacological Research, Vol. 202

  5. Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature

    Expert Opinion on Drug Safety

  6. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database

    Schizophrenia Research, Vol. 268, pp. 118-130

  7. Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 20, Núm. 8, pp. 857-871

  8. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK

    Schizophrenia Research, Vol. 268, pp. 175-188

  9. The European List of Key Medicines for Medical Education: A Modified Delphi Study

    Clinical Pharmacology and Therapeutics, Vol. 115, Núm. 3, pp. 515-524

  10. Using artificial intelligence to create diverse and inclusive medical case vignettes for education

    British Journal of Clinical Pharmacology, Vol. 90, Núm. 3, pp. 640-648

2023

  1. A Clinical Pharmacology and Therapeutics Teacher's Guide to Race-Based Medicine, Inclusivity, and Diversity

    Clinical Pharmacology and Therapeutics, Vol. 113, Núm. 3, pp. 600-606

  2. Analysis of deprescription strategies of proton pump inhibitors in primary care: A narrative review

    Primary Health Care Research and Development, Vol. 24

  3. Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project

    European Journal of Clinical Pharmacology, Vol. 79, Núm. 4, pp. 571-574

  4. Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom

    Journal of Clinical Psychopharmacology, Vol. 43, Núm. 3, pp. 239-245

  5. Functional Status of Patients over 65 Years Old Intervened on for a Hip Fracture One Year after the Operation

    Healthcare (Switzerland), Vol. 11, Núm. 10

  6. Knowledge, use and opinion about written informed consent in primary healthcare nurses: CONOSER pilot project

    Atencion Primaria, Vol. 55, Núm. 2

  7. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 19, Núm. 2, pp. 57-74

2022

  1. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

    Pharmacopsychiatry, Vol. 55, Núm. 2, pp. 73-86

  2. Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase

    Expert Review of Clinical Pharmacology, Vol. 15, Núm. 1, pp. 65-78

  3. Clozapine and the risk of haematological malignancies

    The Lancet Psychiatry